Novartis focuses its business on three divisions with innovation power and global scale: pharmaceuticals, eye care and generics. These three divisions are supported by our research organization, the Novartis Institutes for BioMedical Research (NIBR), and a centralized services group, Novartis Business Services, to facilitate collaboration across our divisions, and drive efficiency and productivity gains.
We aim to develop innovative products in growing areas of healthcare. At the same time, we are expanding our presence in the emerging markets of Asia, Africa and Latin America, where there is fast-growing demand for access to high-quality medicines and healthcare.
Pharmaceuticals develops innovative, patent-protected medicines to enhance health outcomes for patients and health-care providers. The division is at the forefront of development and commercialization in oncology, primary care and specialty medicines.
Alcon provides innovative products that enhance quality of life by helping people worldwide see better. Its three businesses – Surgical, Ophthalmic Pharmaceuticals and Vision Care – offer the world's widest spectrum of eye care products.
Sandoz is a global leader in the rapidly growing generics industry. Its products – which are focused in Retail Generics, Biopharmaceuticals & Oncology Injectables, and Anti-Infectives – help make affordable, high-quality medicines available to more people.